Form 4 Filing for LeonaBio, Inc. - Insider Transaction

Mark James Litton, President and CEO of LeonaBio, Inc. (LONA), acquired 750,000 stock options on April 9, 2026. These options have an exercise price of $9.54 and are set to expire on April 8, 2036. The options are subject to a 48-month vesting schedule, contingent upon continued service as a provider. This transaction, reported on Form 4, indicates a significant grant of equity-based compensation to a key executive.